Thrombopoietin Completed Phase 4 Trials for Thrombocytopenia After Chemotherayp in AML / Thrombocytopenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02267993Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients